Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Citizen Petitions Seeking To Delay Product Approvals Continue To Swamp FDA

This article was originally published in The Pink Sheet Daily

Executive Summary

Agency's latest report to Congress highlights resource burden, implies legislative fix may better discourage frivolous petitions.

Advertisement

Related Content

Citizen Petitions Targeting ANDAs Recede, But Concerns Over Resources Remain
FDA Status Updates On Citizen Petitions Would Not Signal Decision Pending
FDA To Implement Live Citizen Petition Status Updates
Copaxone Generics: FDA Approval Standards Defy Teva’s Argument On Complexity
Citizen Petitions: FDA Sees Increase In Requests For Reconsideration, Serial Filings
FDA Will Summarily Deny Petitions Submitted Solely To Block ANDA Approvals

Topics

Related Companies

Related Deals

Advertisement
UsernamePublicRestriction

Register

PS078978

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel